Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 1692234 Seattle, WA
Back to RNAC Full portfolio

Position in RNAC

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$50,880
+$45,659 QoQ
Shares Held
4,883
+475.1% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 95 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. RNAC ranks #230 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in RNAC

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $50,880 4,883
2026-03-31 $5,221 849
2025-12-31 $6,121 849
2025-09-30 $7,838 767
2025-06-30 $571 55
2024-06-30 $4,105 152
2024-03-31 $137 211
2023-12-31 $145 211
2023-09-30 $18,157 17,131
2023-06-30 $52,080 46,501
2023-03-31 $62,278 44,805
2022-12-31 $51,684 45,739
2022-09-30 $76,842 46,856
2022-06-30 $72,779 55,557
2022-03-31 $85,386 69,420
2021-12-31 $392,666 120,450
2021-09-30 $819,567 197,012
2021-06-30 $1,203,202 287,848
2021-03-31 $1,432,170 316,502
2020-12-31 $376,252 124,176
2020-09-30 $20,703 8,348
2020-06-30 $23,708 8,348